Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting ...
Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...
Late-Breaking Science Abstract LB 032 - In a phase III clinical trial in China, stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days starting ...
Headline inflation during November and December remained below the tolerance band of the inflation target. The revised ...
There is a reason the image of the Viceroy returns so easily in Polish political language. Whether one reaches back to ...
From lowering cholesterol to feeding your gut microbiome, here’s why this breakfast staple is so good for us and how to reap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results